Skip to main content

Table 1 Baseline characteristics at the time of the index AMI and corresponding values at 2 years of follow-up

From: Determinants of suboptimal long-term secondary prevention of acute myocardial infarction: the structural interview method and physical examinations

 

At baseline n = 200

At 2 years of follow-up n = 200

P-values

Age

63.3 ± 9.7

65.5 ± 9,8

 

Smoker

45 (22.5)

25 (12.5)

< 0.001

Overweight*

129 (65.5)

144 (72)

< 0.001

Systolic BP (mmHg)

146.8 ± 23.4

137.5 ± 18.0

< 0.001

Diastolic BP (mmHg)

91.3 ± 15.0

79.6 ± 10.3

< 0.001

Heart rate (beats/min)

75.6 ± 18.8

62.1 ± 10.6

< 0.001

Hypertension

102 (51.0)

123 (63.4) (n = 194)#

0.157

Hyperlipidemia

53 (26.5)

115 (63.5) (n = 181)#

0.209

Diabetes type1/type2

26 (13.0)

43 (21.8) (n = 197)#

0.259

Heart failure

6 (3.0)

14 (7)

< 0.001

Atrial fibrillation

8 (4.0)

29 (14.8) (n = 196)#

0.439

Stroke or TIA

12 (6.0)

14 (7.2) (n = 194)#

0.319

Renal failure

4 (2.0)

9 (4.5)

< 0.001

Aspirin

199 (99.5)

183 (91.5) (n = 199)#

0.774

Betablockers

187 (93.5)

166 (84.3) (n = 197)#

0.452

Statins

193 (96.5)

177 (89.4) (n = 198)#

0.628

ACE-inhibitors or ARB

177 (88.5)

153 (76.5)

0.463

  1. *BMI ≥ 25 kg/m2. BP Blood pressure, IHD Ischemic heart disease, TIA Transient ischemic attack, ACE Angiotensin converting enzyme, ARB Angiotensin receptor blockers. Data are expressed as mean ± SD or n (%)
  2. #Actual number of patients at 2 years of follow-up